INTS logo
INTS NASDAQ US

Intensity Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Jun 2023
$5.70
▲ +$0.01 (+0.19%)
Vol 24K
2
Quality Score
fail
Mkt Cap
$24.6M
ROE
-370.9%
D/E
0.00
Beta
4.18
52W
$0–$3

Wall Street Consensus

12 analysts · Apr 2026
2
Strong Buy
9
Buy
1
Hold
0
Sell
0
Strong Sell
91.7%
Buy Rating

Price Chart

Earnings

Beat rate: 60.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-1.28 $-1.31 $-0.04
Sep 2025 $-2.23 $-1.50 +$0.73
Jun 2025 $-5.04 $-3.25 +$1.79
Mar 2025 $-4.97 $-5.50 $-0.53

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -612.4% -612.4% -612.4% -612.4% -370.9% -370.9%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 1.40 1.40 1.40 1.40 3.60 3.60

Key Ratios

ROA (TTM)
-214.6%
P/B
9.1
EPS (TTM)
$-0.64
52W High
$3.17
52W Low
$0.19
$0.19 52-Week Range $3.17

How does INTS compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

INTS AAPG ABEO ABOS ABP

INTS valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
9.1
270% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

INTS profitability vs Biotechnology peers

ROE
-370.9%
451% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-214.6%
359% below peers (-46.7%)
vs Peers
vs Industry
Weak

INTS financial health vs Biotechnology peers

D/E ratio
0.0
0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
3.6
19% below peers (4.4)
vs Peers
vs Industry
Below avg
Beta
4.2
331% above peers (1.0)
vs Peers
vs Industry
More volatile

INTS fundamentals radar

INTS Peer median Industry

INTS profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

INTS vs peers: key metrics